|
Today's Headlines
Antiretroviral therapy should be offered to all patients as soon as possible, regardless of CD4 cell count, according to new recommendations offered during the AIDS 2012: XIX International AIDS Conference. » Full article
|
|
A coalition of 37 doctors, researchers, and public health officials petitioned FDA on July 25 to tighten label restrictions for opioid analgesics in an effort to curb prescription drug abuse. » Full article
|
ADVERTISEMENT
Don't Miss Managed Care Pharmacy's Premier Education Event
Want to hear the latest and network within the managed care industry? Attend the Academy of Managed Care Pharmacy's 2012 Educational Conference in Cincinnati, Ohio, October 3-5.
 www.amcpmeetings.org
|
|
It's important to put processes in place to be sure a patient's medication list at discharge from the hospital is the same information that is provided to the primary care physician to avoid medication errors, a recent study reports. » Full article
|
|
FDA has approved a prescription fish oil formulation for the treatment of very high levels of triglycerides, according to Amarin, the New Jersey-based biopharmaceutical company that developed the product. » Full article
|
ADVERTISEMENT
New Drug Price Type Options:
 White Paper
Two new and different methods to ascertain true drug acquisition cost can save money on Rx drug benefits. Read white paper for details and comparison of NADAC and PAC. |
|
CONTINUING EDUCATION
As advocates of public health through immunization, pharmacists can build public awareness, identify patient needs, and provide vaccination services.
To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to login.
|
|
EDITOR'S PICK
A new study of patients with moderate-to-severe Alzheimer's disease found that extended treatment with donepezil could improve cognition and function for even severe patients; however, experts caution that the benefits of the drug were modest. » Full article
|
Survey
a) Significant growth in pharmacy costs, overcome by more significant reduction in medical costs
b) Modest growth in pharmacy costs, overcome by more significant reduction in medical costs
c) A wash: Any growth in pharmacy costs offset by comparable reduction in medical costs
d) Modest growth in pharmacy costs, NOT offset by medical cost savings
e) Significant growth in pharmacy costs, NOT offset by medical cost savings
Respond here and see what your colleagues think too.
Want to see the results of our last survey regarding strategies to best curb prescription painkiller abuse? Click here.
|
|
|
Like
Tweet
